mustang → CapableOf → partnered to advance the development of car t
Typicality: 0.367
Saliency: 0.274
Facets 2
with top medical institutions 12 other
to develop proprietary chimeric antigen receptor 3 purpose
Open triples 2
mustang → partnered to advance → the development of car t 6
mustang → partnered to develop → car t 3
Sentiment analysis
negative neutral positive
0.006 0.674 0.320
Other statistics
Raw frequency 9
Normalized frequency 0.274
Modifier score 0.500
Perplexity 166.560